Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Medication Treatment of Metastatic Bone Disease market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Medication Treatment of Metastatic Bone Disease market. Detailed analysis of key players, along with key growth strategies adopted by Medication Treatment of Metastatic Bone Disease industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Chemotherapy
Hormone Therapy
Bisphosphonates
Opiate Therapy
Immunotherapy
By End-User:
Hospitals
Clinics
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Medication Treatment of Metastatic Bone Disease Market
-
1.3 Market Segment by Type
-
1.3.1 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Chemotherapy from 2016 to 2027
-
1.3.2 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Hormone Therapy from 2016 to 2027
-
1.3.3 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Bisphosphonates from 2016 to 2027
-
1.3.4 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Opiate Therapy from 2016 to 2027
-
1.3.5 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Immunotherapy from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Medication Treatment of Metastatic Bone Disease Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Medication Treatment of Metastatic Bone Disease by Major Types
-
3.4.1 Market Size and Growth Rate of Chemotherapy
-
3.4.2 Market Size and Growth Rate of Hormone Therapy
-
3.4.3 Market Size and Growth Rate of Bisphosphonates
-
3.4.4 Market Size and Growth Rate of Opiate Therapy
-
3.4.5 Market Size and Growth Rate of Immunotherapy
4 Segmentation of Medication Treatment of Metastatic Bone Disease Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Medication Treatment of Metastatic Bone Disease by Major End-Users
-
4.4.1 Market Size and Growth Rate of Medication Treatment of Metastatic Bone Disease in Hospitals
-
4.4.2 Market Size and Growth Rate of Medication Treatment of Metastatic Bone Disease in Clinics
-
4.4.3 Market Size and Growth Rate of Medication Treatment of Metastatic Bone Disease in Others
5 Market Analysis by Regions
-
5.1 China Medication Treatment of Metastatic Bone Disease Production Analysis by Regions
-
5.2 China Medication Treatment of Metastatic Bone Disease Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Medication Treatment of Metastatic Bone Disease Landscape Analysis
-
6.1 North China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major Types
-
6.2 North China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major End-Users
7 Central China Medication Treatment of Metastatic Bone Disease Landscape Analysis
-
7.1 Central China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major Types
-
7.2 Central China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major End-Users
8 South China Medication Treatment of Metastatic Bone Disease Landscape Analysis
-
8.1 South China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major Types
-
8.2 South China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major End-Users
9 East China Medication Treatment of Metastatic Bone Disease Landscape Analysis
-
9.1 East China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major Types
-
9.2 East China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major End-Users
10 Northeast China Medication Treatment of Metastatic Bone Disease Landscape Analysis
-
10.1 Northeast China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major Types
-
10.2 Northeast China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major End-Users
11 Southwest China Medication Treatment of Metastatic Bone Disease Landscape Analysis
-
11.1 Southwest China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major Types
-
11.2 Southwest China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major End-Users
12 Northwest China Medication Treatment of Metastatic Bone Disease Landscape Analysis
-
12.1 Northwest China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major Types
-
12.2 Northwest China Medication Treatment of Metastatic Bone Disease Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Company 1
-
13.1.1 Company 1 Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Company 2
-
13.2.1 Company 2 Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Company 3
-
13.3.1 Company 3 Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Company 4
-
13.4.1 Company 4 Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Company 5
-
13.5.1 Company 5 Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Company 6
-
13.6.1 Company 6 Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Company 7
-
13.7.1 Company 7 Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Company 8
-
13.8.1 Company 8 Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Company 9
-
13.9.1 Company 9 Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Company 10
-
13.10.1 Company 10 Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Chemotherapy from 2016 to 2027
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Hormone Therapy from 2016 to 2027
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Bisphosphonates from 2016 to 2027
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Opiate Therapy from 2016 to 2027
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Immunotherapy from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure China Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Medication Treatment of Metastatic Bone Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Medication Treatment of Metastatic Bone Disease Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Medication Treatment of Metastatic Bone Disease
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Medication Treatment of Metastatic Bone Disease by Different Types from 2016 to 2027
-
Table Consumption Share of Medication Treatment of Metastatic Bone Disease by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Chemotherapy
-
Figure Market Size and Growth Rate of Hormone Therapy
-
Figure Market Size and Growth Rate of Bisphosphonates
-
Figure Market Size and Growth Rate of Opiate Therapy
-
Figure Market Size and Growth Rate of Immunotherapy
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Medication Treatment of Metastatic Bone Disease by Different End-Users from 2016 to 2027
-
Table Consumption Share of Medication Treatment of Metastatic Bone Disease by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Others
-
Table China Medication Treatment of Metastatic Bone Disease Production by Regions
-
Table China Medication Treatment of Metastatic Bone Disease Production Share by Regions
-
Figure China Medication Treatment of Metastatic Bone Disease Production Share by Regions in 2016
-
Figure China Medication Treatment of Metastatic Bone Disease Production Share by Regions in 2021
-
Figure China Medication Treatment of Metastatic Bone Disease Production Share by Regions in 2027
-
Table China Medication Treatment of Metastatic Bone Disease Consumption by Regions
-
Table China Medication Treatment of Metastatic Bone Disease Consumption Share by Regions
-
Figure China Medication Treatment of Metastatic Bone Disease Consumption Share by Regions in 2016
-
Figure China Medication Treatment of Metastatic Bone Disease Consumption Share by Regions in 2021
-
Figure China Medication Treatment of Metastatic Bone Disease Consumption Share by Regions in 2027
-
Table North China Medication Treatment of Metastatic Bone Disease Consumption by Types from 2016 to 2027
-
Table North China Medication Treatment of Metastatic Bone Disease Consumption Share by Types from 2016 to 2027
-
Figure North China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2016
-
Figure North China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2021
-
Figure North China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2027
-
Table North China Medication Treatment of Metastatic Bone Disease Consumption by End-Users from 2016 to 2027
-
Table North China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users from 2016 to 2027
-
Figure North China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2016
-
Figure North China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2021
-
Figure North China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2027
-
Table Central China Medication Treatment of Metastatic Bone Disease Consumption by Types from 2016 to 2027
-
Table Central China Medication Treatment of Metastatic Bone Disease Consumption Share by Types from 2016 to 2027
-
Figure Central China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2016
-
Figure Central China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2021
-
Figure Central China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2027
-
Table Central China Medication Treatment of Metastatic Bone Disease Consumption by End-Users from 2016 to 2027
-
Table Central China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2016
-
Figure Central China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2021
-
Figure Central China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2027
-
Table South China Medication Treatment of Metastatic Bone Disease Consumption by Types from 2016 to 2027
-
Table South China Medication Treatment of Metastatic Bone Disease Consumption Share by Types from 2016 to 2027
-
Figure South China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2016
-
Figure South China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2021
-
Figure South China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2027
-
Table South China Medication Treatment of Metastatic Bone Disease Consumption by End-Users from 2016 to 2027
-
Table South China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users from 2016 to 2027
-
Figure South China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2016
-
Figure South China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2021
-
Figure South China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2027
-
Table East China Medication Treatment of Metastatic Bone Disease Consumption by Types from 2016 to 2027
-
Table East China Medication Treatment of Metastatic Bone Disease Consumption Share by Types from 2016 to 2027
-
Figure East China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2016
-
Figure East China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2021
-
Figure East China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2027
-
Table East China Medication Treatment of Metastatic Bone Disease Consumption by End-Users from 2016 to 2027
-
Table East China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users from 2016 to 2027
-
Figure East China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2016
-
Figure East China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2021
-
Figure East China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2027
-
Table Northeast China Medication Treatment of Metastatic Bone Disease Consumption by Types from 2016 to 2027
-
Table Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2016
-
Figure Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2021
-
Figure Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2027
-
Table Northeast China Medication Treatment of Metastatic Bone Disease Consumption by End-Users from 2016 to 2027
-
Table Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2016
-
Figure Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2021
-
Figure Northeast China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2027
-
Table Southwest China Medication Treatment of Metastatic Bone Disease Consumption by Types from 2016 to 2027
-
Table Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2016
-
Figure Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2021
-
Figure Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2027
-
Table Southwest China Medication Treatment of Metastatic Bone Disease Consumption by End-Users from 2016 to 2027
-
Table Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2016
-
Figure Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2021
-
Figure Southwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2027
-
Table Northwest China Medication Treatment of Metastatic Bone Disease Consumption by Types from 2016 to 2027
-
Table Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2016
-
Figure Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2021
-
Figure Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by Types in 2027
-
Table Northwest China Medication Treatment of Metastatic Bone Disease Consumption by End-Users from 2016 to 2027
-
Table Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2016
-
Figure Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2021
-
Figure Northwest China Medication Treatment of Metastatic Bone Disease Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Company 1
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 1
-
Figure Sales and Growth Rate Analysis of Company 1
-
Figure Revenue and Market Share Analysis of Company 1
-
Table Product and Service Introduction of Company 1
-
Table Company Profile and Development Status of Company 2
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 2
-
Figure Sales and Growth Rate Analysis of Company 2
-
Figure Revenue and Market Share Analysis of Company 2
-
Table Product and Service Introduction of Company 2
-
Table Company Profile and Development Status of Company 3
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 3
-
Figure Sales and Growth Rate Analysis of Company 3
-
Figure Revenue and Market Share Analysis of Company 3
-
Table Product and Service Introduction of Company 3
-
Table Company Profile and Development Status of Company 4
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 4
-
Figure Sales and Growth Rate Analysis of Company 4
-
Figure Revenue and Market Share Analysis of Company 4
-
Table Product and Service Introduction of Company 4
-
Table Company Profile and Development Status of Company 5
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 5
-
Figure Sales and Growth Rate Analysis of Company 5
-
Figure Revenue and Market Share Analysis of Company 5
-
Table Product and Service Introduction of Company 5
-
Table Company Profile and Development Status of Company 6
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 6
-
Figure Sales and Growth Rate Analysis of Company 6
-
Figure Revenue and Market Share Analysis of Company 6
-
Table Product and Service Introduction of Company 6
-
Table Company Profile and Development Status of Company 7
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 7
-
Figure Sales and Growth Rate Analysis of Company 7
-
Figure Revenue and Market Share Analysis of Company 7
-
Table Product and Service Introduction of Company 7
-
Table Company Profile and Development Status of Company 8
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 8
-
Figure Sales and Growth Rate Analysis of Company 8
-
Figure Revenue and Market Share Analysis of Company 8
-
Table Product and Service Introduction of Company 8
-
Table Company Profile and Development Status of Company 9
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 9
-
Figure Sales and Growth Rate Analysis of Company 9
-
Figure Revenue and Market Share Analysis of Company 9
-
Table Product and Service Introduction of Company 9
-
Table Company Profile and Development Status of Company 10
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 10
-
Figure Sales and Growth Rate Analysis of Company 10
-
Figure Revenue and Market Share Analysis of Company 10
-
Table Product and Service Introduction of Company 10
-
